arrow
T

Tereza Ševčíková

University of Ostrava
H指数:19
被引数:1,414

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance

基因组技术在多发性骨髓瘤中不断发展的作用:对诊断、风险分层和耐药性的影响

2026-03-300
OAAI
ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance

ULK4和CDKN2A基因多态性影响不明原因单克隆丙种球蛋白病的发病风险

2026-03-110
OAAI
European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma

欧洲骨髓瘤网络工作组关于下一代测序在 newly diagnosed multiple myeloma 预后分层中应用的共识声明

2025-10-130
OAAI
Elevated circulating tumor cells reflect high proliferation and genomic complexity in multiple myeloma

升高的循环肿瘤细胞反映了多发性骨髓瘤中高增殖和基因组复杂性

2025-09-230
PREAI
Level of Clonal Plasma Cells in Hematopoietic Cell Autografts Reflects the Pre-Transplant Bone Marrow Minimal Residual Disease in Multiple Myeloma Patients

造血细胞自体移植物中克隆浆细胞的水平反映了多发性骨髓瘤患者移植前的骨髓微小残留病

2025-01-151
OA
Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine
2022-01-135
OAAI
Limited efficacy of daratumumab in multiple myeloma with extramedullary disease
LEUKEMIA
IF13.4
2021-07-1028
PREAI
Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis
2020-05-071
OAAI
Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination
LEUKEMIA
IF13.4
2019-10-0846
PREAI
Genome of Leptomonas pyrrhocoris: a high-quality reference for monoxenous trypanosomatids and new insights into evolution of Leishmania
2016-03-2969
OAAI